Look behind the lecture: the added value of NMAs and ITCs in health technology assessment

Written by DAAN REID (UNIVERSITY MEDICAL CENTER GRONINGEN)
Decision science Health technology assessment ISPOR Look behind the lecture Methodology Real-world evidence Stakeholder engagement

In this feature, following participating in a Workshop at the International Society for Pharmacoeconomics and Outcomes Research’s 2021 virtual annual meeting (Virtual ISPOR 2021; 17–20 May), Daan Reid (University Medical Center Groningen, The Netherlands) discusses the GetReal Initiative, as well as the potential added value associated with network meta-analyses (NMAs) and indirect treatment comparisons (ITCs) in the context of health technology assessment. Please could you introduce yourself, your organization(s) and provide a brief summary of your career to date? I work for the University Medical Center Groningen – the largest academic hospital in the north of The Netherlands – as...

To view this content, please register now for access

It's completely free